D-Index & Metrics Best Publications
Biology and Biochemistry
China
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 73 Citations 14,984 350 World Ranking 16042 National Ranking 174
Biology and Biochemistry D-index 73 Citations 14,984 351 World Ranking 3808 National Ranking 87

Research.com Recognitions

Awards & Achievements

2023 - Research.com Biology and Biochemistry in China Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • DNA

Guiyuan Li mainly investigates Cancer research, Nasopharyngeal carcinoma, Carcinogenesis, microRNA and Cancer. His work carried out in the field of Cancer research brings together such families of science as Epithelial–mesenchymal transition, Gene knockdown, Signal transduction, MAPK/ERK pathway and Regulation of gene expression. His Nasopharyngeal carcinoma research incorporates themes from Epstein–Barr virus, Long non-coding RNA, Oncogene and Pathology.

His biological study spans a wide range of topics, including Cell cycle, Aurora kinase, Aurora Kinase A and Immunology. Guiyuan Li has included themes like Drosha, Gene expression profiling, Molecular biology, Competing endogenous RNA and Dicer in his microRNA study. His Cancer study combines topics in areas such as Computational biology and Bioinformatics.

His most cited work include:

  • Circular RNAs function as ceRNAs to regulate and control human cancer progression. (326 citations)
  • Circular RNAs function as ceRNAs to regulate and control human cancer progression. (326 citations)
  • MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression (325 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Cancer research, Nasopharyngeal carcinoma, Carcinogenesis, Molecular biology and Cancer. His Cancer research study combines topics from a wide range of disciplines, such as Cell growth, Cancer cell, microRNA, Metastasis and Cell cycle. In his study, which falls under the umbrella issue of Cell cycle, RNA is strongly linked to Cell biology.

His work investigates the relationship between Nasopharyngeal carcinoma and topics such as Gene expression that intersect with problems in Regulation of gene expression. His Carcinogenesis research integrates issues from Colorectal cancer, Oncogene, Immunology and Transcription factor. Guiyuan Li interconnects Apoptosis, Oncology and Bioinformatics in the investigation of issues within Cancer.

He most often published in these fields:

  • Cancer research (73.46%)
  • Nasopharyngeal carcinoma (44.08%)
  • Carcinogenesis (30.33%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cancer research (73.46%)
  • Nasopharyngeal carcinoma (44.08%)
  • Metastasis (23.22%)

In recent papers he was focusing on the following fields of study:

Guiyuan Li mostly deals with Cancer research, Nasopharyngeal carcinoma, Metastasis, Cancer and Carcinogenesis. His work deals with themes such as Cancer cell, Cell, Immune system and Cell growth, which intersect with Cancer research. His work in Nasopharyngeal carcinoma addresses subjects such as Virus, which are connected to disciplines such as Lymphoma.

The various areas that Guiyuan Li examines in his Metastasis study include Cell migration, microRNA, Long non-coding RNA and Vimentin. His studies in Cancer integrate themes in fields like Biomarker, Non-coding RNA, Circular RNA and Bioinformatics. His Carcinogenesis research is multidisciplinary, relying on both RNA, Regulation of gene expression, Transcriptome and Oncogene.

Between 2017 and 2021, his most popular works were:

  • Circular RNAs function as ceRNAs to regulate and control human cancer progression. (326 citations)
  • Circular RNAs function as ceRNAs to regulate and control human cancer progression. (326 citations)
  • Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities. (152 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • DNA

Guiyuan Li focuses on Cancer research, Nasopharyngeal carcinoma, Cancer, RNA and Metastasis. Guiyuan Li interconnects Wnt signaling pathway, Signal transduction, Cancer cell, Immune system and Radioresistance in the investigation of issues within Cancer research. His Nasopharyngeal carcinoma research is multidisciplinary, incorporating perspectives in Cell migration and Blot.

Guiyuan Li combines subjects such as Virus, Epstein–Barr virus, Circular RNA and Public health with his study of Cancer. His RNA research incorporates elements of Translation, Computational biology and Cell biology. Within one scientific family, he focuses on topics pertaining to microRNA under Metastasis, and may sometimes address concerns connected to Mesenchymal stem cell and Lung cancer.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Circular RNAs function as ceRNAs to regulate and control human cancer progression.

Yaxian Zhong;Yaxian Zhong;Yajun Du;Yajun Du;Xue Yang;Xue Yang;Yongzhen Mo;Yongzhen Mo.
Molecular Cancer (2018)

631 Citations

MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression

Ming Zhou;Ming Zhou;Zixing Liu;Yuhua Zhao;Yan Ding.
Journal of Biological Chemistry (2010)

460 Citations

Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities.

Yazhuo Zhang;Yazhuo Zhang;Mengfang Xia;Mengfang Xia;Ke Jin;Shufei Wang.
Molecular Cancer (2018)

335 Citations

circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a

Rongfang He;Rongfang He;Rongfang He;Peng Liu;Xiaoming Xie;Yujuan Zhou.
Journal of Experimental & Clinical Cancer Research (2017)

324 Citations

Circular RNAs in human cancer

Yumin Wang;Yongzhen Mo;Zhaojian Gong;Xiang Yang.
Molecular Cancer (2017)

298 Citations

Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT

Xina Zhang;Xina Zhang;Buqing Sai;Buqing Sai;Fan Wang;Fan Wang;Lujuan Wang;Lujuan Wang.
Molecular Cancer (2019)

286 Citations

Neoantigen vaccine: an emerging tumor immunotherapy

Miao Peng;Miao Peng;Yongzhen Mo;Yian Wang;Pan Wu.
Molecular Cancer (2019)

263 Citations

A Susceptibility Locus at Chromosome 3p21 Linked to Familial Nasopharyngeal Carcinoma

Wei Xiong;Zhao Yang Zeng;Jia Hui Xia;Kun Xia.
Cancer Research (2004)

258 Citations

Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma.

Hao Bo;Zhaojian Gong;Wenling Zhang;Xiayu Li.
Oncotarget (2015)

245 Citations

Role of metabolism in cancer cell radioresistance and radiosensitization methods.

Le Tang;Le Tang;Fang Wei;Fang Wei;Yingfen Wu;Yi He;Yi He.
Journal of Experimental & Clinical Cancer Research (2018)

244 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Guiyuan Li

Cijun Shuai

Cijun Shuai

Central South University

Publications: 68

Ming Zhou

Ming Zhou

Central South University

Publications: 21

Xiaoling Li

Xiaoling Li

Ministry of Education of the People's Republic of China

Publications: 17

Kwok Wai Lo

Kwok Wai Lo

Chinese University of Hong Kong

Publications: 14

Hui Wang

Hui Wang

Central South University

Publications: 13

George A. Calin

George A. Calin

The University of Texas MD Anderson Cancer Center

Publications: 12

Yi Xin Zeng

Yi Xin Zeng

Sun Yat-sen University

Publications: 12

Sai Wah Tsao

Sai Wah Tsao

University of Hong Kong

Publications: 12

John Ding-E Young

John Ding-E Young

Chang Gung Biotechnology Corp.

Publications: 10

Wei Xiong

Wei Xiong

University of Pittsburgh

Publications: 10

Yan Zhang

Yan Zhang

Chinese Academy of Sciences

Publications: 10

Soldano Ferrone

Soldano Ferrone

Harvard University

Publications: 10

Burton B. Yang

Burton B. Yang

University of Toronto

Publications: 9

Federica Cavallo

Federica Cavallo

University of Turin

Publications: 9

Behzad Baradaran

Behzad Baradaran

Tabriz University of Medical Sciences

Publications: 8

Ya Cao

Ya Cao

Central South University

Publications: 8

Trending Scientists

Arnold L. Rosenberg

Arnold L. Rosenberg

University of Massachusetts Amherst

S. Mani Sarathy

S. Mani Sarathy

King Abdullah University of Science and Technology

Vahid Nourani

Vahid Nourani

University of Tabriz

Jitka Ulrichová

Jitka Ulrichová

Palacký University, Olomouc

Greg Elgar

Greg Elgar

Genomics England

Victor Markowitz

Victor Markowitz

Lawrence Berkeley National Laboratory

Ramiro Logares

Ramiro Logares

Spanish National Research Council

Joseph B. Williams

Joseph B. Williams

The Ohio State University

Paul J. Taylor

Paul J. Taylor

University of Melbourne

Juan A. Ordóñez

Juan A. Ordóñez

Complutense University of Madrid

Richard M. Friedman

Richard M. Friedman

University of British Columbia

Hideo Tsukada

Hideo Tsukada

Hamamatsu Photonics (Japan)

Frini Karayanidis

Frini Karayanidis

University of Newcastle Australia

Daniel J. Sexton

Daniel J. Sexton

Duke University

Thomas C. Smyrk

Thomas C. Smyrk

Mayo Clinic

Something went wrong. Please try again later.